WASHINGTON — PhRMA has already spent $21 million on lobbying this year — a sum that puts it on course to smash its previous annual lobbying records.
The group, which represents dozens of major drug makers, spent nearly $6 million on advocacy in the third quarter of this year, according to lobbying disclosures released Monday, about $400,000 more than it spent in the same period last year. After an unprecedented first half of 2018, that total puts it just $4 million shy of a new record annual spend —and it hasn’t spent less than $4 million in a quarter since 2015.
About the Author Reprints
Would you be interested in material showing a major Pharmaceutical company has “misrepresented” is nuclear isotope Sestamibi for decades and making hundreds of millions of dollars off those lies?
Show me the article